FACS showed that there was a significant scavenging effect on tumor-infiltrated Tregs after anti-CD25 antibody injection in control (CTR) and CD24+MDSC-DCs groups, although the number of Tregs was low in CD24+MDSC-DCs-treated mice (Fig. 4Band4D). This evidence concerns the gene CD24 and neoplasm.